Antihypertensive Therapy and Incidence of Type 2 Diabetes in an Elderly Cohort
Response to Chan et al.
- Raj S. Padwal, MD, FRCP1 and
- Andreas Laupacis, MD, FRCP234
- 1Division of General Internal Medicine, University of Alberta, Edmonton, Alberta, Canada
- 2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
- 3Faculty of Medicine, Department of Health Policy Management and Evaluation, Toronto, Ontario, Canada
- 4Sunnybrook and Women’s College Health Sciences Center, Toronto, Ontario, Canada
- Address correspondence to Raj S. Padwal, MD, FRCP, Internal Medicine, University of Alberta, 2E3.22 Walter C. Mackenzie Health Sciences Center, 8440-112th St., Edmonton, Alberta, T6G 2B7, Canada. E-mail: rpadwal{at}yahoo.com
We thank Chan et al. (1) for their interest in our article and agree that selection bias and a relatively short duration of follow-up (primarily due to a high rate of censoring) are potential limitations to our study. These and other potential limitations are described in detail in our discussion section (2). It should be noted that the cohort was comprised of 76,176 individuals in the primary analysis and 100,653 individuals in the secondary …
